Furthermore, CARD9 deletion in mice with metabolic disorders and obesity improved glucose intolerance, decreased cardiac fibrosis and cardiac dysfunction, reduced cardiac macrophage infiltration into the heart, lowered proinflammatory cytokine production, and attenuated MAPK activity 6,12,13. The gene discussed is CARD9; the disease is Obesity.